Buprenorphine Transdermal Patches Market Report

Global Buprenorphine Transdermal Patches Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：181
  • REPORT CODE：GMM841345
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Buprenorphine Transdermal Patches market report explains the definition, types, applications, major countries, and major players of the Buprenorphine Transdermal Patches market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • PurduePharma

    • Grunenthal

    • Luye Pharma

    By Type:

    • 5mcg/h

    • 75mcg/h

    • 10mcg/h

    • 15 mcg/h

    • 20 mcg/h

    By End-User:

    • Relieve Cancer Pain

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Buprenorphine Transdermal Patches Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Buprenorphine Transdermal Patches Outlook to 2028- Original Forecasts

    • 2.2 Buprenorphine Transdermal Patches Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Buprenorphine Transdermal Patches Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Buprenorphine Transdermal Patches Market- Recent Developments

    • 6.1 Buprenorphine Transdermal Patches Market News and Developments

    • 6.2 Buprenorphine Transdermal Patches Market Deals Landscape

    7 Buprenorphine Transdermal Patches Raw Materials and Cost Structure Analysis

    • 7.1 Buprenorphine Transdermal Patches Key Raw Materials

    • 7.2 Buprenorphine Transdermal Patches Price Trend of Key Raw Materials

    • 7.3 Buprenorphine Transdermal Patches Key Suppliers of Raw Materials

    • 7.4 Buprenorphine Transdermal Patches Market Concentration Rate of Raw Materials

    • 7.5 Buprenorphine Transdermal Patches Cost Structure Analysis

      • 7.5.1 Buprenorphine Transdermal Patches Raw Materials Analysis

      • 7.5.2 Buprenorphine Transdermal Patches Labor Cost Analysis

      • 7.5.3 Buprenorphine Transdermal Patches Manufacturing Expenses Analysis

    8 Global Buprenorphine Transdermal Patches Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Buprenorphine Transdermal Patches Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Buprenorphine Transdermal Patches Export by Region (Top 10 Countries) (2017-2028)

    9 Global Buprenorphine Transdermal Patches Market Outlook by Types and Applications to 2022

    • 9.1 Global Buprenorphine Transdermal Patches Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 5mcg/h Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 75mcg/h Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global 10mcg/h Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global 15 mcg/h Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global 20 mcg/h Consumption and Growth Rate (2017-2022)

    • 9.2 Global Buprenorphine Transdermal Patches Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Relieve Cancer Pain Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Buprenorphine Transdermal Patches Market Analysis and Outlook till 2022

    • 10.1 Global Buprenorphine Transdermal Patches Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.2.2 Canada Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.2.3 Mexico Buprenorphine Transdermal Patches Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.2 UK Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.3 Spain Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.4 Belgium Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.5 France Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.6 Italy Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.7 Denmark Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.8 Finland Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.9 Norway Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.10 Sweden Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.11 Poland Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.12 Russia Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.3.13 Turkey Buprenorphine Transdermal Patches Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.2 Japan Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.3 India Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.4 South Korea Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.5 Pakistan Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.6 Bangladesh Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.7 Indonesia Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.8 Thailand Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.9 Singapore Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.10 Malaysia Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.11 Philippines Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.4.12 Vietnam Buprenorphine Transdermal Patches Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.5.2 Colombia Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.5.3 Chile Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.5.4 Argentina Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.5.5 Venezuela Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.5.6 Peru Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.5.7 Puerto Rico Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.5.8 Ecuador Buprenorphine Transdermal Patches Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.6.2 Kuwait Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.6.3 Oman Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.6.4 Qatar Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Buprenorphine Transdermal Patches Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.7.2 South Africa Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.7.3 Egypt Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.7.4 Algeria Buprenorphine Transdermal Patches Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Buprenorphine Transdermal Patches Consumption (2017-2022)

      • 10.8.2 New Zealand Buprenorphine Transdermal Patches Consumption (2017-2022)

    11 Global Buprenorphine Transdermal Patches Competitive Analysis

    • 11.1 PurduePharma

      • 11.1.1 PurduePharma Company Details

      • 11.1.2 PurduePharma Buprenorphine Transdermal Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 PurduePharma Buprenorphine Transdermal Patches Main Business and Markets Served

      • 11.1.4 PurduePharma Buprenorphine Transdermal Patches Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Grunenthal

      • 11.2.1 Grunenthal Company Details

      • 11.2.2 Grunenthal Buprenorphine Transdermal Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Grunenthal Buprenorphine Transdermal Patches Main Business and Markets Served

      • 11.2.4 Grunenthal Buprenorphine Transdermal Patches Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Luye Pharma

      • 11.3.1 Luye Pharma Company Details

      • 11.3.2 Luye Pharma Buprenorphine Transdermal Patches Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Luye Pharma Buprenorphine Transdermal Patches Main Business and Markets Served

      • 11.3.4 Luye Pharma Buprenorphine Transdermal Patches Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    12 Global Buprenorphine Transdermal Patches Market Outlook by Types and Applications to 2028

    • 12.1 Global Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global 5mcg/h Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global 75mcg/h Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global 10mcg/h Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global 15 mcg/h Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global 20 mcg/h Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Relieve Cancer Pain Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Buprenorphine Transdermal Patches Market Analysis and Outlook to 2028

    • 13.1 Global Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.2.2 Canada Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.2 UK Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.3 Spain Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.5 France Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.6 Italy Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.8 Finland Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.9 Norway Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.11 Poland Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.12 Russia Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.2 Japan Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.3 India Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.5.3 Chile Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.5.6 Peru Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.6.3 Oman Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Buprenorphine Transdermal Patches Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Buprenorphine Transdermal Patches

    • Figure of Buprenorphine Transdermal Patches Picture

    • Table Global Buprenorphine Transdermal Patches Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Buprenorphine Transdermal Patches Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global 5mcg/h Consumption and Growth Rate (2017-2022)

    • Figure Global 75mcg/h Consumption and Growth Rate (2017-2022)

    • Figure Global 10mcg/h Consumption and Growth Rate (2017-2022)

    • Figure Global 15 mcg/h Consumption and Growth Rate (2017-2022)

    • Figure Global 20 mcg/h Consumption and Growth Rate (2017-2022)

    • Figure Global Relieve Cancer Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Buprenorphine Transdermal Patches Consumption by Country (2017-2022)

    • Table North America Buprenorphine Transdermal Patches Consumption by Country (2017-2022)

    • Figure United States Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Canada Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Mexico Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Table Europe Buprenorphine Transdermal Patches Consumption by Country (2017-2022)

    • Figure Germany Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure UK Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Spain Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Belgium Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure France Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Italy Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Denmark Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Finland Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Norway Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Sweden Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Poland Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Russia Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Turkey Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Table APAC Buprenorphine Transdermal Patches Consumption by Country (2017-2022)

    • Figure China Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Japan Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure India Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure South Korea Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Thailand Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Singapore Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Philippines Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Table South America Buprenorphine Transdermal Patches Consumption by Country (2017-2022)

    • Figure Brazil Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Colombia Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Chile Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Argentina Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Peru Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Table GCC Buprenorphine Transdermal Patches Consumption by Country (2017-2022)

    • Figure Bahrain Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Oman Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Qatar Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Table Africa Buprenorphine Transdermal Patches Consumption by Country (2017-2022)

    • Figure Nigeria Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure South Africa Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Egypt Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure Algeria Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Table Oceania Buprenorphine Transdermal Patches Consumption by Country (2017-2022)

    • Figure Australia Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Buprenorphine Transdermal Patches Consumption and Growth Rate (2017-2022)

    • Table PurduePharma Company Details

    • Table PurduePharma Buprenorphine Transdermal Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table PurduePharma Buprenorphine Transdermal Patches Main Business and Markets Served

    • Table PurduePharma Buprenorphine Transdermal Patches Product Portfolio

    • Table Grunenthal Company Details

    • Table Grunenthal Buprenorphine Transdermal Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grunenthal Buprenorphine Transdermal Patches Main Business and Markets Served

    • Table Grunenthal Buprenorphine Transdermal Patches Product Portfolio

    • Table Luye Pharma Company Details

    • Table Luye Pharma Buprenorphine Transdermal Patches Sales, Price, Value and Gross Profit (2017-2022)

    • Table Luye Pharma Buprenorphine Transdermal Patches Main Business and Markets Served

    • Table Luye Pharma Buprenorphine Transdermal Patches Product Portfolio

    • Figure Global 5mcg/h Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 75mcg/h Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 10mcg/h Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 15 mcg/h Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 20 mcg/h Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Relieve Cancer Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Buprenorphine Transdermal Patches Consumption Forecast by Country (2022-2028)

    • Table North America Buprenorphine Transdermal Patches Consumption Forecast by Country (2022-2028)

    • Figure United States Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Buprenorphine Transdermal Patches Consumption Forecast by Country (2022-2028)

    • Figure Germany Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Buprenorphine Transdermal Patches Consumption Forecast by Country (2022-2028)

    • Figure China Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Buprenorphine Transdermal Patches Consumption Forecast by Country (2022-2028)

    • Figure Brazil Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Buprenorphine Transdermal Patches Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Buprenorphine Transdermal Patches Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Buprenorphine Transdermal Patches Consumption Forecast by Country (2022-2028)

    • Figure Australia Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Buprenorphine Transdermal Patches Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US